Drugs News and Research

RSS

Study shows direct cellular interaction between endocannabinoids and alcohol in the brain

In findings that should finally put to rest a decade of controversy in the field of neurobiology, a team at The Scripps Research Institute has found decisive evidence that a specific neurotransmitter system-the endocannabinoid system-is active in a brain region known to play a key role in the processing of memory, emotional reactions, and addiction formation. The new study also shows that this system can dampen the effects of alcohol, suggesting an avenue for the development of drugs to combat alcohol addiction.

13 May 2010

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

Graymark Healthcare, Inc. today announced progress on Fiscal 2010 Initiatives and financial results for the Quarter ending March 31, 2010.

13 May 2010

ACHN reports net loss of $5.6M for first-quarter 2010: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Achillion Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

13 May 2010

Study reveals increase in treatment admissions for drug abuse

From 1998 to 2008 there were marked changes in some patterns of substance use treatment admissions according to a study by the Substance Abuse and Mental Health Services Administration (SAMHSA). Although the concurrent abuse of both alcohol and drugs has remained widespread, the proportion of treatment admissions for the co-abuse of these substances has declined gradually yet significantly during this period - from 44 percent to 38 percent.

13 May 2010

SAGE launches further two Therapeutic Advances journals

SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles: Therapeutic Advances in Chronic Disease and Therapeutic Advances in Endocrinology and Metabolism.

13 May 2010

25% of adults quit their overactive bladder medication: Study

Study of 5,392 adults found that a quarter had quit their overactive bladder medication, with nine out of ten saying it didn't work as expected or they couldn't tolerate it. A follow-up study found that being a current smoker raised the risk of quitting by 80%, having an enlarged prostate by 74% and believing that bladder medication caused side effects by 111%.

13 May 2010

NPTA launches new ACPE-accredited certification course to improve safety of pharmacy technicians

The National Pharmacy Technician Association is doing its part to improve the safety of pharmacy technicians with the launch of a new ACPE-accredited certification course on the safe handling of hazardous medications, also referred to as Chemo Certification.

13 May 2010

Celera to present on AIDS pandemic, AZT drugs at Computational Molecular Biology Symposium

In 1985 there was little hope for people with AIDS. Newspapers and television screens were filled with ghastly pictures of emaciated figures dying from a disease that had no cure.

13 May 2010

FDA Advisory Committee planned to review Lux Biosciences' NDA for voclosporin

Isotechnika Pharma Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration is scheduled to review partner, Lux Biosciences', New Drug Application for voclosporin on June 28, 2010.

13 May 2010

Study: Treating serious gum disease in diabetics can help lower blood sugar levels

Researchers have found that reducing inflammation of the gums in people with diabetes can help lower the risk of serious complications associated with the condition, such as eye problems and heart disease.

13 May 2010

Research sheds light on prenatal heart formation, chromosome 22q.11 deletion syndrome

Researchers studying the common genetic disorder chromosome 22q.11 deletion syndrome have identified key proteins that act together to regulate early embryonic development. One protein is essential to life; in animal studies, embryos without the protein do not survive past the first few days of gestation.

13 May 2010

AHF targets BMS over pricing and policies for its HIV/AIDS drug

AIDS Healthcare Foundation will host a protest Wednesday morning, May 12th at 10:30am targeting New York-based Bristol Myers Squibb Co. over the pricing and policies for its key HIV/AIDS drug, Reyataz, one of the most expensive first-line AIDS treatment in the US, during the Bank of America-Merrill Lynch 2010 Health Care Conference.

13 May 2010

FDA should apply equal rigor in assessing food claims and drug approvals, says new report

The U.S. Food and Drug Administration should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says a new report from the Institute of Medicine.

13 May 2010

CTI to conduct phase II study of pixantrone in patients with HER2-negative breast cancer

Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.

13 May 2010

FDA urges doctors to police drug ads

A new Federal Drug Administration program will urge doctors to blow the whistle on misleading drug advertisements.

13 May 2010

ABMC reports 7.6% increase in first-quarter 2010 net sales

American Bio Medica Corporation announced today its financial results for the three months ended March 31, 2010.

13 May 2010

Avexa halts HIV drug trials

Melbourne-based biotech Avexa has announced the closure of its lead HIV program for apricitabine after failing to attract a licensing partner for the Phase III drug.

12 May 2010

NIH awards PLx Pharma multiple grants for development of GI safer NSAIDs

PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.

12 May 2010

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Drug-releasing stents are more effective than bare metal stents at keeping a blocked artery open after angioplasty, but the difference does not result in fewer deaths or subsequent heart attacks after the procedure, according to a review of recent studies.

12 May 2010

Academic scientist receives $125,000 from ADDF/LBDA program to study LBD

The Alzheimer's Drug Discovery Foundation and the Lewy Body Dementia Association announced today the recipient of their first partnership research award through the Lewy Body Dementia Biomarker Research Program.

12 May 2010

Drugs News and Research

Study shows direct cellular interaction between endocannabinoids and alcohol in the brain

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

ACHN reports net loss of $5.6M for first-quarter 2010: MicroStockProfit.com

Study reveals increase in treatment admissions for drug abuse

SAGE launches further two Therapeutic Advances journals

25% of adults quit their overactive bladder medication: Study

NPTA launches new ACPE-accredited certification course to improve safety of pharmacy technicians

Celera to present on AIDS pandemic, AZT drugs at Computational Molecular Biology Symposium

FDA Advisory Committee planned to review Lux Biosciences' NDA for voclosporin

Study: Treating serious gum disease in diabetics can help lower blood sugar levels

Research sheds light on prenatal heart formation, chromosome 22q.11 deletion syndrome

AHF targets BMS over pricing and policies for its HIV/AIDS drug

FDA should apply equal rigor in assessing food claims and drug approvals, says new report

CTI to conduct phase II study of pixantrone in patients with HER2-negative breast cancer

FDA urges doctors to police drug ads

ABMC reports 7.6% increase in first-quarter 2010 net sales

Avexa halts HIV drug trials

NIH awards PLx Pharma multiple grants for development of GI safer NSAIDs

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Academic scientist receives $125,000 from ADDF/LBDA program to study LBD

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News